Unos astrónomos han descubierto un exoplaneta (planeta de fuera de nuestro sistema solar) de tamaño similar al de la Tierra y que, al parecer, está cubierto en buena parte por volcanes. El planeta, llamado LP 791-18 d, podría sufrir erupciones volcánicas con tanta …
Planeta abarrotado de volcanes pero potencialmente habitable Read More »
Besarse en la boca es un acto tan típico entre amantes que difícilmente podemos plantearnos si comenzó a hacerse en una época concreta de la historia de la humanidad. Nunca sabremos cuál fue el primer beso entre amantes, pero sí podemos averiguar cu …
Laekna, a clinical-stage biotechnology company dedicated to bringing novel therapies to cancer and liver fibrosis patients worldwide, announced that the U.S. Food and Drug Administration has cleared the Investigational New Drug application of LAE102 antibody to initiate clinical development.
Laekna announces first IND clearance by U.S. FDA for internally-discovered LAE102 Read More »
BioArctic AB’s partner Eisai announced that they have submitted a Marketing Authorisation Application for lecanemab, an investigational anti-amyloid beta protofibril antibody, for the treatment of early Alzheimer’s disease with confirmed amyloid pathology in the brain, to the UK Medicines and Healthcare products Regulatory Agency in Great Britain.
Marketing Authorisation Application for lecanemab submitted in Great Britain: BioArctic Read More »
Kelyniam Global, a leading maker of custom cranial implants, announced results for its quarter ended March 31, 2023.
En la búsqueda de un préstamo rápido online, los usuarios navegan por toda la web investigando cada una de las financieras que promocionan el servicio. Sin embargo, para tomar la decisión puede pasar mucho tiempo. Para evitar tanto proceso, una excelente alterna …
Aquí está uno de los mejores comparadores de préstamos de España Read More »
Blueprint Medicines, Opiant Pharmaceuticals and Lexicon Pharmaceuticals are all awaiting FDA decisions this week.
More than $5 billion poured into the longevity space in 2022, and experts say the science is now primed to make a real difference in extending human healthspan.
Biopharma Targets the Untapped Potential of the Human Healthspan Read More »
ReCode plans to use its SORT LNP genetic medicines delivery technology to treat CF and PCD patients who don’t respond to current treatments.
The extensive discussion between the FDA’s advisory committee, company representatives and other interested parties could serve as a cautionary tale to developers of future gene therapies.
Opinion: Sarepta Enters Uncharted Territory with Adcomm Approval Read More »
